Your browser doesn't support javascript.
loading
KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.
Stringaris, Kate; Marin, David; Barrett, A John; Hills, Robert; Sobieski, Catherine; Cao, Kai; Saltarrelli, Jerome G; Daher, May; Shaim, Hila; Smith, Nathaniel; Linch, David; Gale, Rosemary; Allen, Christopher; Sekine, Takuya; Mehta, Rohtesh; Champlin, Richard; Shpall, Elizabeth J; Kantarjian, Hagop; Garcia-Manero, Guillermo; Rezvani, Katayoun.
Afiliação
  • Stringaris K; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Marin D; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Barrett AJ; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Hills R; Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Sobieski C; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Cao K; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Saltarrelli JG; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Daher M; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Shaim H; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Smith N; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Linch D; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom; and.
  • Gale R; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom; and.
  • Allen C; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom; and.
  • Sekine T; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Mehta R; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Champlin R; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Shpall EJ; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
  • Kantarjian H; Leukemia Department, MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Leukemia Department, MD Anderson Cancer Center, Houston, TX.
  • Rezvani K; Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.
Blood ; 128(24): 2819-2823, 2016 12 15.
Article em En | MEDLINE | ID: mdl-27760759
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Haplótipos / Receptores KIR Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Haplótipos / Receptores KIR Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido